📣 A major milestone for the A-TANGO project: The first patient with #ACLF has started treatment in the Phase 2 trial evaluating the investigational #G-TAK combination therapy. A crucial step towards developing new treatment options for this life-threatening condition! 🔗 a-tango.eu/wp-content/u...

Back home from an inspiring & energising #EASLCongress in sunny + hot Barcelona 🌅. These were my personal highlights (sound on 🔊) - what were your‘s? 😎 #Barcelona #EASL2026 #LiverDisease #LiverHealth #ACLF @europeliver.bsky.social @medblab.bsky.social @horizoneu.bsky.social @easlnews.bsky.social

👏 3 more outstanding posters 📣 from the coordinating institute UCL at #EASLCongress 2026 - great job, Supacha & Jinxia! 1️⃣ Ammonia-induced bioenergetic failure via #TLR4🔋 2️⃣ YAQ006 and YAQ005 reduce mortality in #ACLF☠️ 3️⃣ Yaq-001 ameliorates liver injury via gut #microbiome🦠 @rajivjalan.bsky.social

💫 Three outstanding Charité posters at #EASLCongress 2026 in Barcelona - well done, Sina, Joscha & Alex! 1️⃣ Body composition & survival in HRS-AKI 2️⃣ Macrophages & gut barrier failure in alcoholic hepatitis🍷 3️⃣ Thrombin generation🩸in #cirrhosis & #ACLF @easlnews.bsky.social @europeliver.bsky.social

🌍 Which #ACLF score performs best? In 3,370 COSSH cohort patients, the A-TANGO score matched the COSSH-ACLF Score for ACLF diagnosis + short-term #mortality prediction, while other models markedly underestimated ACLF. 👉 Visit Meiqian Hu's poster tomorrow! 🔍 #Poster SAT-476 @rajivjalan.bsky.social

🧪 A deep dive into basic & translational science: Minneke Coenraad (LUMC) chaired today's last #PosterTour on "Experimental and Pathophysiology" at the Cirrhosis & Complications Track Hub! 💫 Meiqian Hu from Rajiv Jalan's group (UCL) did a fantastic job presenting her poster! #EASLCongress #EASL2026

🤩 Great attendance & active discussion at #EASLCongress today! Very insightful & interactive Networking Session on the evolving definition and #RiskStratification of ACLF, highlighting the new #ATANGOscore & the urgent need for international #Harmonisation of #ACLF criteria. @rajivjalan.bsky.social

At today’s J Hep Symposium, Benedikt Hofer (author) & Annalisa Berzigotti (challenger) discussed abstinence-induced #Recompensation in #Alcohol-related #Cirrhosis, chaired by Frank Tacke (Charité). 👉 Sustained abstinence = lower mortality 🍷⛔ #EASLCongress #LiverDisease @jhepatology.bsky.social

🧬 Novel #biomarker composites may help predict #AKI and #mortality following acute decompensation of #cirrhosis. 📍Presented in #POSTER WED-448-YI by Olivia Greenham et al. during #EASLCongress 2026! #RiskStratification #LiverDisease #Patients @europeliver.bsky.social @rajivjalan.bsky.social

🧬 Genetic #Cholestasis in adults: When to test? That's the question A-TANGO consortium member Thomas Berg asked today as chair + speaker in the Ipsen Symposium "Rare Genetic #LiverDiseases - Bridging the Gap from #GeneticTesting to #PatientManagement". #EASL2026 #RareDiseases @easlnews.bsky.social

📢 Full house at the EF CLIF Networking Session today at #EASLCongress here in their local Barcelona 😎 An exciting new initiative is a new #MasterProgramme, starting in Fall 2026🎓 #cirrhosis #ACLF #LiverFailure #EASL2026 @decision4liver.bsky.social @microb-predict.bsky.social @a-tango.bsky.social

🧠 The modified hepatic encephalopathy staging tool (mHEST) outperformed West Haven criteria in diagnostic consistency and prognostic performance. #POSTER TOP-471-YI by Annarein Kerbert et al. #EASL2026 #HepaticEncephalopathy #Cirrhosis #Hepatology @rajivjalan.bsky.social @europeliver.bsky.social

In the co-session 'Patient/provider communication', @korenjak.bsky.social (president of @europeliver.bsky.social) stresses three vital in this communication relationship: ⏳ Time 📍Point-of-view 💬Miscommunication @microb-predict.bsky.social @a-tango.bsky.social #EASL2026 #EASLCongress

📣 SNEAK PEEK 🔍 of posters, talks, networking sessions & chairing activities by Consortium Members during #EASLCongress next week (27-30 May 2026) in Barcelona! #ACLF #cirrhosis #LiverDisease #LiverFailure #Hepatology #LiverSky @rajivjalan.bsky.social @europeliver.bsky.social @easlnews.bsky.social

🥳 Join the A-TANGO Networking Session at #EASLCongress! 🗓 Fri, 29 May 2026 ⏰ 10:00–10:30 📍 Cirrhosis & Complications Track Hub 6 The A-TANGO Score: A Novel Tool for Risk Stratification & #ClinicalEndpoints in #ACLF @rajivjalan.bsky.social @easlnews.bsky.social @europeliver.bsky.social

📣 Join the MICROB-PREDICT Consensus Conference at #EASLCongress next week! 📅 Wed, 27 May | 15:30 – 18:30 h 📍 Jansen Room, Hall 8.0, Fira Gran Via (North Access) 👥 Open to registered EASL attendees 📌 On-site event #Microbiome #Hepatology #Cirrhosis #ACLF @easlnews.bsky.social @medblab.bsky.social

🥳 How are you planning to celebrate #WorldLiverDay? And what do you do to strengthen your own liver? #SolidHabitsStrongLiver 👉 Eat healthy - daily 🥦 👉 Move your body - daily 🥎🎾🏃‍➡️ 👉 Reduce alcohol - always🍷 ➡️ 🥛 (there is no "safe" amount of alcohol) 👉 Get your liver checked regularly by a doctor 🩺

📣 IMAC invites you to an upcoming webinar examining how evidence in rare disease trials can be interpreted more rigorously. 🎓 𝗙𝗿𝗼𝗺 𝗙𝘂𝘁𝗶𝗹𝗶𝘁𝘆 𝘁𝗼 𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴: 𝗪𝗵𝗮𝘁 𝗮 𝗕𝗮𝘆𝗲𝘀𝗶𝗮𝗻 𝗟𝗲𝗻𝘀 𝗥𝗲𝘃𝗲𝗮𝗹𝘀 𝗶𝗻 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗧𝗿𝗶𝗮𝗹𝘀 📅 April 9 ⏰ 4:00 pm CET 👉 Register here: events.teams.microsoft.com/event/9ed2de...

📣 New publication introducing the A-TANGO Organ Failure (OF) score for improved detection of acute-on-chronic liver failure #ACLF in patients with acute #decompensation of #cirrhosis 👍3,896 patients 👍validated in India & China 👍improves diagnostic accuracy www.sciencedirect.com/science/arti...

Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts

Acute-on-chronic liver failure (ACLF) is characterised by multiorgan failure and high short-term mortality in hospitalised cirrhosis patients with acu…

sciencedirect.com

🚀 Motivation boost to kick off the new year 🙂: The European Commission agreed to provide a 6-month-long extension to A-TANGO! Let's use this momentum and move forward swiftly now, so that A-TANGO can bring the much-needed G-TAK therapy for severe #AlcoholicHepatitis #cirrhosis #ACLF to the market.

🥂 We have good news for the holidays: The technical hold-up in the EU portal has finally been resolved & we submitted the 3rd #PeriodicReport ☺️ Wishing everyone relaxing holidays❄️ Together, we are moving from bench to bedside to bring innovative therapies to #ACLF patients @rajivjalan.bsky.social

As the year draws to a close, we are wrapping up 2025 with gratitude, momentum, and a spirit of community at concentris. ✨ 💡Curious about what’s next in 2026, and how these developments could support your work? Read our latest #newsletter: 🔗 mailchi.mp/concentris/n...

New calls & Project highlights from concentris

Calls opening soon *** EU Clusters in cancer prevention & environmental health, *** New QSPainRelief Database *** Important Policy Recommendations for people with Down syndrome from GO-DS21 *** Pediat...

mailchi.mp

On Wednesday, 26 Nov, at 6 pm CET, EASL Studio hosts a new episode titled “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance” The episode will be broadcast live on EASL.eu and can be accessed here: 📹 easl.eu/easl-studio-... Don't miss it ☺️

👏 1st Site Visit Completed for A-TANGO's #ClinicalTrial: Thanks to big efforts by Yaqrit + Royal Free Hospital, we have kicked off our Phase 2a trial, evaluating the safety of #TLR4 antagonist in combination with #G-CSF for the treatment of #ACLF! #BenchToBedside #cirrhosis @rajivjalan.bsky.social

For #WorldHepatitisDay we stand together 🩺 At A‑TANGO, we aim to transform healthcare for people with #LiverDisease, including those living with #cirrhosis and #ACLF, putting #patients first ☺️ Every person deserves timely, effective, and #stigma‑free support 💪 @europeliver.bsky.social @who.int

What an inspiring 9th Steering Committee Meeting! It was lovely to meet fellow liver-health enthusiasts & clinical investigators who recently joined the #GTAK Study. Let's include as many #ACLF patients in the study as possible.💉😊 #AlcoholicHepatitis @europeliver.bsky.social @easlnews.bsky.social

Join this exciting event! Don't miss our #OpenInnovation event, uniting experts in #DrugDevelopment, #bioinformatics, and #hepatology. Connect with researchers, industry professionals, and investors to share insights & explore collaboration opportunities! 🚀 Register now: inevent.uk/en/Crowdheli...

📣 Secure your spot now 📣: inevent.uk/en/Crowdheli... Check out our upcoming (online) A-TANGO #LiverHealth Helix Event! 🟣 Industrial Perspective on #DrugDevelopment Challenges for #ClinicalTrials 🗓️ 04 June 2025 🕙 Begin: 10 am BST #ClinicalResearch @rajivjalan.bsky.social @easlnews.bsky.social

At #EASL2025, ELPA President Marko Korenjak presented 3 EU projects: A-TANGO, LIVER AIM & THRIVE. At the Layperson Events, science met real stories — patients at the center of innovation, action & hope. @liveraim.bsky.social @A-TANGO @THRIVE @korenjak.bsky.social @ninadonner.bsky.social

✅ How to reach a #consensus in science 🧬: Clinic director Frank Tacke (Charité) trains future #hepatology leaders on the #DelphiMethod, a reliable forecasting method using multiple rounds of questionnaires for an expert panel to reach a mutual agreement. 🗓️ What a fun #workshop at #EASLCongress 2025